RegeneRx

RegeneRx is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of wounds and rare diseases. Read more

J.J Finkelstein's photo - President & CEO of RegeneRx

President & CEO

J.J Finkelstein

CEO Approval Rating

88/100

Founded:

1982

Status:

PublicIndependent CompanyOTCMKTSRGRX

REGENERX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Neotherix has been one of RegeneRx's top competitors. Neotherix's headquarters is in York, England, and was founded in 2007. Neotherix is in the Health Care Services industry. Neotherix generates 1,954% of RegeneRx's revenue.

Harmony Biosciences is one of RegeneRx's top rivals. Harmony Biosciences is a Public company that was founded in Plymouth Meeting, Pennsylvania in 2017. Harmony Biosciences operates in the Pharmaceuticals industry. Harmony Biosciences has 147 more employees vs. RegeneRx.

MicroCures is perceived as one of RegeneRx's biggest rivals. MicroCures was founded in 2011, and is headquartered in New York, New York. MicroCures operates in the Biotechnology industry. MicroCures generates $1.9M more revenue vs. RegeneRx.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is viDA a competitor of RegeneRx?

RegeneRx Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

RegeneRx's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 1.5B. Over the last four quarters, RegeneRx's revenue has decreased by 0%. Specifically, in Q1 2021's revenue was $ < 1M; in Q4 2020, it was $ < 1M; in Q3 2020, it was $ < 1M; in Q2 2020, RegeneRx's revenue was $ < 1M.

RegeneRx Acquisitions

No recent acquisitions found related to RegeneRx

RegeneRx Funding History

Since RegeneRx was founded in 1982, it has participated in 8 rounds of funding. In total RegeneRx has raised $7.2M. RegeneRx's last funding round was on Oct 2020 for a total of $500.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Convertible Note
Oct 2020
$500K
-
Convertible Note
Feb 2019
$1.3M
-
Equity
Mar 2018
$888.3K
-
Equity
Jun 2016
$1.8M
Equity
Jan 2011
$950K
-

Since RegeneRx was founded in 1982, it has participated in 8 rounds of funding. In total RegeneRx has raised $7.2M. RegeneRx's last funding round was on Oct 2020 for a total of $500.0K

RegeneRx Investments

No recent investments found related to RegeneRx

RegeneRx News

February 24, 2021Markets Insider

RegeneRx JV Locks Clinical Trial Database for Phase 3 Dry Eye Trial

ROCKVILLE, Md., Feb. 24, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ('the C... See more »
January 26, 2021Markets Insider

RegeneRx Comments on ARISE-3 Clinical Trial

ROCKVILLE, Md., Jan. 26, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ('the C... See more »
December 21, 2020MarketScreener

RegeneRx Issues Year End Letter To Stockholders

(marketscreener.com) ROCKVILLE, Md., Dec. 21, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. ... See more »
November 9, 2020MarketScreener

Last Patient, Last Visit Completed in RegeneRx Phase 3 Dry Eye Clinical Trial

(marketscreener.com) ROCKVILLE, Md., Nov. 9, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. ,... See more »
October 28, 2020MarketScreener

RegeneRx Joint Venture Enrolls Last Subject in Phase 3 Dry Eye Trial

(marketscreener.com) ROCKVILLE, Md., Oct. 28, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. ... See more »
October 26, 2020VisionMonday

RegeneRx Closes Convertible Debt Financing

ROCKVILLE, Md.-RegeneRx Biopharmaceuticals (OTCQB: RGRX), a clinical-stage drug development company f... See more »
October 21, 2020Baltimore Citybizlist

RegeneRx Closes Convertible Debt Financing

RegeneRx Press Releases

March 27, 2019PR Newswire

RegeneRx to Present at 2019 Spring Investor Summit

ROCKVILLE, Md., March 27, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... See more »
October 29, 2018PR Newswire

RegeneRx Partner Updates on Clinical Trials

ROCKVILLE, Md., Oct. 29, 2018 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the C... See more »
September 6, 2018PR Newswire

World Health Organization Recommends INN for Thymosin Beta 4 as "timbetasin"

ROCKVILLE, Md., Sept. 6, 2018 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the C... See more »
February 22, 2018PR Newswire

Key U.S. Dry Eye Patent Issued to RegeneRx

ROCKVILLE, Md., Feb. 22, 2018 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)("the Co... See more »
February 14, 2018StreetInsider

RegeneRx Receives Canadian Patent for Treating Neurological Injury and Damage

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug ... See more »
October 31, 2017PR Newswire

RegeneRx JV Announces Results of ARISE-2 Dry Eye Trial

ROCKVILLE, Md., Oct. 31, 2017 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the C... See more »
August 29, 2017Blackbird

RegeneRx Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York September 10-12, 2017

Presenting on Monday, September 11 at 11:40 AM ETROCKVILLE, Md., Aug. 30, 2017 /PRNewswire/ -- Regene... See more »

Social Media

RegeneRx Headquarters

15245 Shady Grove Road Suite 470

Rockville, Maryland20850

1-301-208-9191

Driving Directions »

Trending Companies

RegeneRx Summary

ABOUT

Overview

RegeneRx is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of wounds and rare diseases. RegeneRx was founded in 1982. RegeneRx's headquarters is located in Rockville, Maryland, USA 20850. I...

CEO

RegeneRx's President & CEO, J.J Finkelstein, currently has an approval rating of 88%. RegeneRx's primary competitors are Neotherix, Harmony Biosciences & MicroCures.

Frequently Asked Questions about RegeneRx

  1. When was RegeneRx founded?

    RegeneRx was founded in 1982
  2. Who is RegeneRx's CEO?

    RegeneRx's CEO is J.J Finkelstein
  3. How much revenue does RegeneRx generate?

    RegeneRx generates $ < 1M in revenue
  4. How much funding does RegeneRx have?

    RegeneRx has historically raised $7.2M in funding
  1. Where is RegeneRx's headquarters?

    RegeneRx's headquarters is in Rockville Maryland, USA
  2. How many employees does RegeneRx have?

    RegeneRx has 3 employees
  3. What sector does RegeneRx operate in?

    RegeneRx is in Health Care Equipment
  4. Who are RegeneRx's competitors?

    RegeneRx's top competitors are Neotherix, Harmony Biosciences, MicroCures